首页 | 本学科首页   官方微博 | 高级检索  
检索        

丙酸倍氯松吸入对儿童支原体感染诱发咳嗽变异性哮喘预后的影响
引用本文:岑赛宁,张国华,蔡卫华.丙酸倍氯松吸入对儿童支原体感染诱发咳嗽变异性哮喘预后的影响[J].中国妇幼保健,2005,20(3):277-278.
作者姓名:岑赛宁  张国华  蔡卫华
作者单位:广东省佛山市妇幼保健院,528000
摘    要:目的 :探讨不同疗程丙酸倍氯松 (BDP)吸入对支原体感染诱发咳嗽变异性哮喘 (CVA)预后的影响。方法 :将 60例血清肺炎支原体IgM抗体呈阳性反应的CVA患儿随机分成长疗程组和短疗程组 ,分别吸入BDP 12~ 2 4周或 2周。结果 :CVA复发率、血清总IgE持续升高率、发展成支气管哮喘率 ,在两组间有显著性差异。结论 :CVA患儿按哮喘病治疗 ,在缓解期后继续给予吸入皮质激素 ,有利于CVA的预后。

关 键 词:哮喘  丙酸倍氯松  疗程  预后
文章编号:1001-4411(2005)03-0277-02

Effect of taking beclomethason dispropionate (BDP) at prognosis of cough variant asthma (CVA) caused by infection of mycoplasma pneumoniae
CEN Sai-Ning,ZHANG Guo-Hua,Cai Wei-hua.Effect of taking beclomethason dispropionate (BDP) at prognosis of cough variant asthma (CVA) caused by infection of mycoplasma pneumoniae[J].Maternal and Child Health Care of China,2005,20(3):277-278.
Authors:CEN Sai-Ning  ZHANG Guo-Hua  Cai Wei-hua
Institution:CEN Sai-Ning,ZHANG Guo-Hua,CAI Wei-Hua.Maternity And Health Hospital of Foshan,Foshan 528000,China
Abstract:Objective:To explore the effect of taking beclomethason dispropionate(BDP) in different period of treatment on prognosis of cough variant asthma(CVA) caused by infection of mycoplasma pneumoniae.Methods:Separating 60 CVA infants whose blood serum mycoplasma pneumoniae IgM antibody is positve randomly into two groups:long period of treatment group in which each takes BDP for 12 to 24 weeks,and short period of treatment group in which each takes BDP for 2 weeks.Results:There is a significant difference between the two groups in the rates of CVA recrudescence,blood serum total IgE continuous raising,and developing into bronchia asthma.Conclusion:It is good for CVA prognosis or for infants suffering from CVA treated as ones suffering from asthma to continue to take BDP after the serious time.
Keywords:Asthma  BDP  Period of treatment  Prognosis
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号